$COSM News

Last published 9h ago

9h agoCOSMCosmos Health Provides U.S. E-Commerce Update for October 2026: Monthly Subscription Value Reaches $1.83 Million, Approximately $22 Million AnnualizedACCESS NewswireCosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its U.S. direct-to-consumer subscription business reached $1,832,785 in monthly subscription value as of October 31, 2026, equivalent to approximately $22.0 million on an annualized basis. In October 2026, the Company's U.S. e-commerce business rec ...
6d agoCOSMCosmos Health's CosmoFarm Begins Commissioning New Automated Order-Processing and Vehicle-Loading Infrastructure, Advancing Capacity That Could Support Over $120 Million in Annual RevenueACCESS NewswireNew order-processing line: automated handling cell and roller conveyor now being commissioned at CosmoFarm's distribution center in Peristeri, Athens, designed to move more orders through the facility in less
1w agoCOSMCosmos Health's Amazon UK Business Surpasses $2 Million in TTM Sales, Up 90%, with a 23% Net Profit Margin; Expects Sales to Grow Approximately 72% to $3.9 Million Over the Next Twelve MonthsACCESS NewswireAmazon UK sales up 90%: $2.27 million in TTM sales for the twelve months to November 2, 2026, up from approximately $1.19 million in the prior twelve months23% net margin on Amazon UK: the Amazon UK channel generated
1w agoCOSMCosmos Health's U.S. Active Subscriptions Surpass 12,000, Up 92% in Two WeeksACCESS NewswireActive subscriptions up 92%: 12,050 active U.S. subscriptions as of October 28, 2026, up from 6,287 on October 14, 2026Monthly subscription value up 94%: $1,787,585 at standard renewal pricing as of October 28, 2026, up
2w agoCOSMNoble Capital Markets Initiates Equity Research Coverage on Cosmos Health with Outperform Rating and $1.40 Price TargetACCESS NewswireRating and price target: Outperform rating with a $1.40 price targetImplied upside: approximately 493% above the $0.236 closing price on Tuesday, October 27, 2026Valuation basis: 1.42 times Noble's 2027 revenue
2w agoCOSMCosmos Health Expands E-Commerce and Subscription Business to Australia, New Zealand and the Broader Oceania Region, With Sales Already UnderwayACCESS NewswireNow live in Oceania: e-commerce subscription business operating across Australia, New Zealand and the broader Oceania region, with sales already underwayAttractive markets: together, Australia and New Zealand represent
3w agoCOSMCosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth and Global ExpansionACCESS NewswireKey HighlightsRecord revenue: preliminary nine-month 2026 revenue of approximately $54.3 million, up 19%, with every quarter of 2026 setting a record2026 outlook reaffirmed: full-year revenue expected to surpass $90
3w agoCOSMCosmos Health Provides Update on United States Business; Q4 2026 U.S. Revenue Expected to Reach $15 Million, with Gross Profit of $10.5 Million; Active U.S. Subscriptions Up 42% from 6,287 to 8,940 in Just Five DaysACCESS Newswire● Q4 2026 U.S. revenue: approximately $15 million expected, based on the Company's current growth trajectory● Q4 2026 gross profit: approximately $10.5 million expected, at an approximately 70% gross margin●
4w agoCOSMCosmos Health Reaches 6,287 Active U.S. Subscriptions, Substantially All Added Since Mid-September, with 60.5% of Online Checkout Orders Including a SubscriptionACCESS Newswire● 6,287 active U.S. subscriptions as of October 14, 2026, the vast majority added since mid-September as the Company accelerates investment in its U.S. platform● 60.5% of U.S. online checkout orders included a
4w agoCOSMCosmos Health Reports Record Single-Day Direct-to-Consumer Sales in the United States Above $92,000, with $902,000 in Sales Over the Past 30 DaysACCESS NewswireRecord day: U.S. direct-to-consumer sales exceeded $92,000 on October 11, 2026, the highest single day to date$902,000 in 30 days: approximately $30,000 in average daily sales over the trailing 30-day
1mo agoCOSMCosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 MillionACCESS NewswireRecord nine-month revenue of approximately $54.3 million - up 19%, or $8.7 million, from $45.6 million in the same period of 2025Nine-month 2026 revenue nearly matches the whole of 2024 - when full-year revenue was
1mo agoCOSMCosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 BillionACCESS NewswireMore than 15 proprietary brands and product lines, plus 10 branded generics - across nutraceuticals, infection control, advanced formulations, skin care and mother & baby, and branded genericsProprietary brands sold
1mo agoCOSMCosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized RevenueACCESS NewswireRecord Q2 2026 revenue of over $15 million, an annualized run-rate of over $60 million, at wholly owned subsidiary CosmoFarmRevenue up 4.3x under Cosmos Health ownership - from ~$14 million in fiscal 2017, the last full
1mo agoCOSMCosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production PipelineACCESS NewswireContract manufacturing pipeline surpasses $20 million in implied revenue at wholly owned subsidiary Cana Laboratories, representing over $18 million in implied gross profit across the life of agreementsGross margins of
1mo agoCOSMCosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since JuneACCESS Newswire7.7 million contracted units added in under two weeks - Cana Laboratories' orderbook has grown from over 12 million units earlier this year to more than 32.7 million todaySecured orders for 1.04 million units
1mo agoCOSMCosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management MarketACCESS NewswirePrime Ledger engaged to structure an asset-specific, non-dilutive tokenized financing for CCX0722 - backed by intellectual property, with no issuance of Cosmos Health common stockPositions Cosmos Health among the
2mo agoCOSMCosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million UnitsACCESS Newswire500,000 contracted units of ROSARTIA annually / 2.5 million over five years through a new long-term agreement at wholly owned subsidiary Cana LaboratoriesExpands Cosmos Health's manufacturing presence in
2mo agoCOSMCosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health MarketACCESS NewswireFirst orders received for the Company's veterinary antimicrobial line, which will be marketed under the brand name C-ScrubVetFormulated for dogs, cats, horses, companion and large animals, and supplied in a 500ml
2mo agoCOSMCosmos Health: A Company Transformed — 2026 Year-to-DateGlobeNewswireA Comprehensive Corporate Summary — January 1, 2026 through August 31, 2026 Revenue record set three consecutive quarters: FY2025 $65.3M (+20%) → Q1 2026 $17.93M (+31%) → Q2 2026 $18.99M (+28.8%) → H1 2026 $36.91M
2mo agoCOSMCosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From ConversionsGlobeNewswire$8 million senior secured ATW convertible note satisfied, together with all accrued interest, twelve months ahead of its August 2027 maturity and eliminating any further dilutionSimplified capital structure, with no
2mo agoCOSMCosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant CategoriesGlobeNewswireCHICAGO, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced it is
2mo agoCOSMCosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year TermGlobeNewswireInitial purchase order of 126,000 Sky Premium Life units secured on execution of the agreementExclusive rights across Saudi Arabia for an initial five years, spanning pharmacies, retail and online platforms, with
2mo agoCOSMCosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program UnderwayGlobeNewswireHighest Q2 and H1 revenue in Company history, reflecting strength across all core segments and reaching a new milestone with an adjusted annualized revenue run-rate exceeding $75 millionContinued progress toward
3mo agoCOSMCosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B ChannelsGlobeNewswireDigital subscription platform brings together the Company’s proprietary consumer health products across consumer (B2C) and corporate (B2B) channelsCustomers can begin through one of three paths: a free nutritionist
3mo agoCOSMCosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 UnitsGlobeNewswireCosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average monthly orders already exceeding 4,500 units, and projected to exceed 54,000 annually Products are distributed across
3mo agoCOSMCosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market RepurchasesGlobeNewswireCHICAGO, July 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has
3mo agoCOSMCosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market RepurchasesGlobeNewswireCHICAGO, July 16, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has
3mo agoCOSMCosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market RepurchasesGlobeNewswireCHICAGO, July 15, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has
4mo agoCOSMCosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market RepurchasesGlobeNewswireCHICAGO, July 14, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has
4mo agoCOSMCosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market RepurchasesGlobeNewswireCHICAGO, July 13, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has
4mo agoCOSMCosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in GreeceGlobeNewswireCosmos Health will supply DIABIT-IS X (sitagliptin), while Libytec handles distribution and promotion in GreeceFive-year agreement expected to contribute to revenue and cash-flow visibilityAs a prescription medicine,
4mo agoCOSMCosmos Health Launches Subscription ModelGlobeNewswireSubscription model already launched with NOOR Collagen in the United StatesEarly data shows a repeat purchase rate above 60% at high margins in excess of 50%Model is designed to drive stronger loyalty, greater lifetime
4mo agoCOSMCosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market RepurchasesGlobeNewswireCHICAGO, July 08, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has
4mo agoCOSMCosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market RepurchasesGlobeNewswireCHICAGO, July 07, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has
4mo agoCOSMCosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share RepurchasesGlobeNewswireRecord Q2 2026 revenue of approximately $19.4 million, up approximately 31.5% year-over-year from $14.75 million in Q2 2025Record first-half 2026 revenue of approximately $37.3 million, up approximately 31% from $28.46
4mo agoCOSMCosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market PurchasesGlobeNewswireCHICAGO, July 06, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has
4mo agoCOSMCosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market PurchasesGlobeNewswireCHICAGO, July 02, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has
4mo agoCOSMCosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current PaceGlobeNewswireCHICAGO, July 01, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has
4mo agoCOSMCosmos Health Authorizes Up to $5 Million Share Repurchase ProgramGlobeNewswireCHICAGO, June 30, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its
4mo agoCOSMCosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life UnitsGlobeNewswireCHICAGO, June 26, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced a
4mo agoCOSMCosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and CanadaGlobeNewswireBuilding on Its Recent Acquisition of the CCX0722 Intellectual Property, Cosmos Health Owns the Technology Outright and Is Now Pursuing Patent Protection Across Four Major Healthcare Markets Within the $190+ Billion
4mo agoCOSMCosmos Health’s C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross MarginGlobeNewswireCHICAGO, June 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided an update on
4mo agoCOSMCosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating EfficiencyGlobeNewswireCHICAGO, June 23, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has
4mo agoCOSMCosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual ProfitGlobeNewswireCumulative orderbook of over 25 million units secured through wholly owned subsidiary Cana Laboratories across multiple EU and international partners.Multi-year agreements extending up to 10 years provide recurring
4mo agoCOSMCosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility CapacityGlobeNewswireCHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly
4mo agoCOSMCosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United StatesGlobeNewswireCHICAGO, June 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced its entry into the
4mo agoCOSMCosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological ProductsGlobeNewswireCHICAGO, June 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that, through its
4mo agoCOSMCosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross ProfitGlobeNewswireCHICAGO, June 15, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided an update on its
5mo agoCOSMCosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of MedicinesGlobeNewswireCHICAGO, June 12, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its
5mo agoCOSMCosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross ProfitGlobeNewswireStrong sales momentum: across the UK and Greece, the brands' first two markets.Over $1.5 million in sales: C-Scrub and C-Sept have generated over $1.5 million in combined annualized sales across the United Kingdom